SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001144204-18-033041
Filing Date
2018-06-06
Accepted
2018-06-06 16:05:50
Documents
12
Effectiveness Date
2018-06-06

Document Format Files

Seq Description Document Type Size
1 DEFA14A tv495625_defa14a.htm DEFA14A 45818
2 GRAPHIC image_001.jpg GRAPHIC 69728
3 GRAPHIC image_002.jpg GRAPHIC 112547
4 GRAPHIC image_003.jpg GRAPHIC 38421
5 GRAPHIC image_004.jpg GRAPHIC 6418
6 GRAPHIC image_005.jpg GRAPHIC 56950
7 GRAPHIC image_006.jpg GRAPHIC 62142
8 GRAPHIC image_007.jpg GRAPHIC 202480
9 GRAPHIC image_008.jpg GRAPHIC 259694
10 GRAPHIC image_009.jpg GRAPHIC 131756
11 GRAPHIC image_010.jpg GRAPHIC 165603
12 GRAPHIC image_011.jpg GRAPHIC 102604
  Complete submission text file 0001144204-18-033041.txt   1698842
Mailing Address 16640 CHESTERFIELD GROVE ROAD SUITE 200 CHESTERFIELD MO 63005
Business Address BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK BALLYCOOLIN DUBLIN L2 15 636-449-1830
AVADEL PHARMACEUTICALS PLC (Filer) CIK: 0001012477 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37977 | Film No.: 18883871
SIC: 2834 Pharmaceutical Preparations